{"disease":{"id":"hemoglobin-h","name":"hemoglobin h"},"drugs":{"marketed":[{"drug_id":"eculizumab-aeeb","indication_name":"Paroxysmal Nocturnal Hemoglobinuria (PNH)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"BKEMV","generic_name":"ECULIZUMAB-AEEB","company_name":"AMGEN INC","drug_phase":"marketed","molecular_target":"","drug_class":"Complement Inhibitor [EPC]","quality_score":20,"revenue":null,"mechanism":""},{"drug_id":"crovalimab","indication_name":"paroxysmal nocturnal hemoglobinuria (PNH)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Piasky","generic_name":"CROVALIMAB","company_name":"Genentech Inc","drug_phase":"marketed","molecular_target":"","drug_class":"Complement C5 Inhibitor [EPC]","quality_score":62,"revenue":null,"mechanism":"Piasky works by blocking the action of the Complement C5 protein, which is involved in the immune system's response to foreign substances."},{"drug_id":"hydroxycarbamide","indication_name":"Hemoglobin SS disease with crisis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Hydroxycarbamide","company_name":"University of Birmingham","drug_phase":"phase_3","molecular_target":"Carbonic anhydrase 2, Carbonic anhydrase 5A, mitochondrial, Carbonic anhydrase 9","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"siklos","indication_name":"Hemoglobin SS disease with crisis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Siklos","company_name":"Theravia","drug_phase":"marketed","molecular_target":"Carbonic anhydrase 2, Carbonic anhydrase 5A, mitochondrial, Carbonic anhydrase 9","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"xromi","indication_name":"Hemoglobin SS disease with crisis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Xromi","company_name":"Nova Laboratories Limited","drug_phase":"marketed","molecular_target":"Carbonic anhydrase 2, Carbonic anhydrase 5A, mitochondrial, Carbonic anhydrase 9","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"hydroxycarbamid","indication_name":"Hemoglobin SS disease with crisis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Hydroxycarbamid","company_name":"Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts","drug_phase":"phase_2","molecular_target":"Carbonic anhydrase 2, Carbonic anhydrase 5A, mitochondrial, Carbonic anhydrase 9","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":6,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05799118","title":"Study of the Role of Genetic Modifiers in Hemoglobinopathies","phase":"","overall_status":"RECRUITING","enrollment_count":30000,"lead_sponsor_name":"Cyprus Institute of Neurology and Genetics","has_results":false},{"nct_id":"NCT05286138","title":"STUDY INCIDENCE AND CHARACTERISTICS OF MALIGNANT NEOPLASIES IN PATIENTS WITH HEMOGLOBINOPATHY FOLLOWED IN ITALY","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Società Italiana Talassemie ed Emoglobinopatie","has_results":false},{"nct_id":"NCT07305181","title":"Prevalence of Abnormal Haemoglobin Variants in Metropolitan Chattogram, Bangladesh","phase":"","overall_status":"COMPLETED","enrollment_count":8400,"lead_sponsor_name":"Bangladesh Bioscience Research Group","has_results":false},{"nct_id":"NCT06767722","title":"Effectiveness of a Lifestyle Intervention for Pregnant Women With Abnormal Glucose Metabolism in Early Pregnancy: EAGM Trial","phase":"NA","overall_status":"RECRUITING","enrollment_count":3430,"lead_sponsor_name":"First Affiliated Hospital, Sun Yat-Sen University","has_results":false},{"nct_id":"NCT04645199","title":"National Longitudinal Cohort of Hematological Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":2300,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false},{"nct_id":"NCT04029142","title":"Screening for Hemoglobinopathies in Pregnant Women","phase":"","overall_status":"COMPLETED","enrollment_count":1785,"lead_sponsor_name":"University Hospital, Basel, Switzerland","has_results":false},{"nct_id":"NCT06903299","title":"Prospective Investigation of Intra-Articular Tranexamic Acid Use in Elective Hip Arthroplasty","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"St. Anne's University Hospital Brno, Czech Republic","has_results":false},{"nct_id":"NCT06958822","title":"Ferric Carboxymaltose Methemoglobinemia Study","phase":"","overall_status":"COMPLETED","enrollment_count":977,"lead_sponsor_name":"Ordu University","has_results":false},{"nct_id":"NCT07180836","title":"Prevalence and Hematological Characteristics of Hemoglobinopathies","phase":"","overall_status":"COMPLETED","enrollment_count":839,"lead_sponsor_name":"Bacha Khan Medical College","has_results":false},{"nct_id":"NCT07207551","title":"Prevalence of Hemoglobinopathies Associated With Significant Hb Variants in the Chattogram Region of Bangladesh","phase":"","overall_status":"COMPLETED","enrollment_count":760,"lead_sponsor_name":"Bangladesh Bioscience Research Group","has_results":false},{"nct_id":"NCT06831799","title":"ERN-EuroBloodNet Registry on Patients With Rare Red Blood Cell Defects and COVID-19","phase":"","overall_status":"COMPLETED","enrollment_count":684,"lead_sponsor_name":"Hospital Universitari Vall d'Hebron Research Institute","has_results":false},{"nct_id":"NCT05852184","title":"Hb Scope: A Multi-Center Validation Trial","phase":"","overall_status":"COMPLETED","enrollment_count":504,"lead_sponsor_name":"China Medical University Hospital","has_results":false},{"nct_id":"NCT05217576","title":"NBM-200 Clinical Study in Blood Donation Setting","phase":"NA","overall_status":"COMPLETED","enrollment_count":387,"lead_sponsor_name":"OneBlood, Inc.","has_results":false},{"nct_id":"NCT07227155","title":"The HOPE Biobank Resource (BMT CTN 2402 HOPE)","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":375,"lead_sponsor_name":"Medical College of Wisconsin","has_results":false},{"nct_id":"NCT04865224","title":"Non-Invasive Estimation of Hemoglobin Levels in Blood Using Combined Deep Learning Methods","phase":"","overall_status":"COMPLETED","enrollment_count":353,"lead_sponsor_name":"Karabuk University","has_results":false},{"nct_id":"NCT00102245","title":"Clinical and Laboratory Investigation of Humans With Informative Iron or Erythroid Phenotypes","phase":"","overall_status":"TERMINATED","enrollment_count":334,"lead_sponsor_name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","has_results":false},{"nct_id":"NCT02946463","title":"ALXN1210 (Ravulizumab) Versus Eculizumab in Complement Inhibitor Treatment-Naïve Adult Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":272,"lead_sponsor_name":"Alexion Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT03355222","title":"Using Eggshell Calcium to Mitigate Fluorosis in Ethiopia","phase":"NA","overall_status":"COMPLETED","enrollment_count":270,"lead_sponsor_name":"University of Saskatchewan","has_results":false},{"nct_id":"NCT04201210","title":"A Trial to Assess Haploidentical T-depleted Stem Cell Transplantation in Patients With SCD","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":212,"lead_sponsor_name":"University of Regensburg","has_results":false},{"nct_id":"NCT03056040","title":"ALXN1210 Versus Eculizumab in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Eculizumab","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":202,"lead_sponsor_name":"Alexion Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT03329365","title":"Paroxysmal Nocturnal Hemoglobinuria in ESUS & ETUS","phase":"","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","has_results":false},{"nct_id":"NCT07445997","title":"The Association Between Preoperative HbA1c Levels and Postoperative Acute Kidney Injury in Isolated Coronary Artery Bypass Surgery","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Osman Sila Aydin","has_results":false},{"nct_id":"NCT03149289","title":"Hepatitis C Virus Infection in Patients With Hemoglobinopathies","phase":"","overall_status":"COMPLETED","enrollment_count":168,"lead_sponsor_name":"Società Italiana Talassemie ed Emoglobinopatie","has_results":false},{"nct_id":"NCT04208529","title":"A Long-term Follow-up Study in Participants Who Received CTX001","phase":"PHASE3","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":160,"lead_sponsor_name":"Vertex Pharmaceuticals Incorporated","has_results":false},{"nct_id":"NCT03138200","title":"The Role of Central Venous Oxygen Saturation (ScvO2) as an Indicator of Blood Transfusion in the Critically Ill","phase":"NA","overall_status":"UNKNOWN","enrollment_count":160,"lead_sponsor_name":"Szeged University","has_results":false},{"nct_id":"NCT06608862","title":"The Impact of Hormonal Contraceptive Use and Lifestyle Factors on Fracture Risk and Bone Quality in Young Female Adults","phase":"","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Bundeswehr University Munich","has_results":false},{"nct_id":"NCT03816514","title":"Noninvasive Hemoglobin Monitoring for Maintaining Hemoglobin Concentration Within the Target Range","phase":"NA","overall_status":"COMPLETED","enrollment_count":130,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT00277849","title":"Collection of Blood From Persons With Hemoglobin and Erythrocyte Polymorphisms for Laboratory Malaria Research","phase":"","overall_status":"COMPLETED","enrollment_count":130,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT07233356","title":"Novel Risk Factors and Localization of Peripheral Arterial Disease","phase":"","overall_status":"COMPLETED","enrollment_count":123,"lead_sponsor_name":"Centre Hospitalier Universitaire de la Guadeloupe","has_results":false},{"nct_id":"NCT00000588","title":"Chelation Therapy of Iron Overload With Pyridoxal Isonicotinoyl Hydrazone","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Case Western Reserve University","has_results":false},{"nct_id":"NCT06933914","title":"Long-term Safety and Tolerability of MY008211A Tablets in Patients With Paroxysmal Nocturnal Hemoglobinuria","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Wuhan Createrna Science and Technology Co., Ltd","has_results":false},{"nct_id":"NCT05389891","title":"Hemoglobinopathy Nursing Program and Pediatric Nursing Students","phase":"NA","overall_status":"COMPLETED","enrollment_count":108,"lead_sponsor_name":"Beni-Suef University","has_results":false},{"nct_id":"NCT06952361","title":"Evaluation of Alternative Transfusion Triggers in Hemodynamically Stable, Non-Ventilated Cancer Patients","phase":"","overall_status":"COMPLETED","enrollment_count":107,"lead_sponsor_name":"Ardak Arynov","has_results":false},{"nct_id":"NCT06313398","title":"Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":false},{"nct_id":"NCT04558918","title":"Study of Efficacy and Safety of Twice Daily Oral LNP023 in Adult PNH Patients With Residual Anemia Despite Anti-C5 Antibody Treatment","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":97,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT07087262","title":"A Phase I Study of SNH-119014 in Healthy Volunteers","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":96,"lead_sponsor_name":"ScinnoHub Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT01529827","title":"Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":94,"lead_sponsor_name":"Roswell Park Cancer Institute","has_results":true},{"nct_id":"NCT04445402","title":"Pediatrics HOT COVID-19 Database in NY Tristate","phase":"","overall_status":"COMPLETED","enrollment_count":77,"lead_sponsor_name":"Columbia University","has_results":false},{"nct_id":"NCT06312644","title":"Study of Ultomiris® (Ravulizumab) Safety in Pregnancy","phase":"","overall_status":"RECRUITING","enrollment_count":75,"lead_sponsor_name":"Alexion Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT00566696","title":"Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological Malignancies","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":73,"lead_sponsor_name":"St. Jude Children's Research Hospital","has_results":true},{"nct_id":"NCT05735717","title":"MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":70,"lead_sponsor_name":"Masonic Cancer Center, University of Minnesota","has_results":false},{"nct_id":"NCT06294301","title":"A Study of Single and Multiple Doses of LP-005 in Healthy Adult Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":68,"lead_sponsor_name":"Longbio Pharma","has_results":false},{"nct_id":"NCT01316549","title":"Study of Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation","phase":"","overall_status":"COMPLETED","enrollment_count":67,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT05125341","title":"Natural History Study of Adult Patients With Paroxysmal Nocturnal Hemoglobinuria of High-risk Hemolysis in China","phase":"","overall_status":"COMPLETED","enrollment_count":67,"lead_sponsor_name":"CARE Pharma Shanghai Ltd.","has_results":false},{"nct_id":"NCT04364685","title":"Effect of Walking on Sand With Dietary Intervention in Overweight Type 2 Diabetes Mellitus Patients.","phase":"NA","overall_status":"COMPLETED","enrollment_count":66,"lead_sponsor_name":"Majmaah University","has_results":false},{"nct_id":"NCT03745287","title":"A Safety and Efficacy Study Evaluating CTX001 in Subjects With Severe Sickle Cell Disease","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":63,"lead_sponsor_name":"Vertex Pharmaceuticals Incorporated","has_results":false},{"nct_id":"NCT06872333","title":"Allo HSCT for High Risk Hemoglobinopathies","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":62,"lead_sponsor_name":"Masonic Cancer Center, University of Minnesota","has_results":false},{"nct_id":"NCT00856388","title":"Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders","phase":"NA","overall_status":"COMPLETED","enrollment_count":62,"lead_sponsor_name":"Roswell Park Cancer Institute","has_results":true},{"nct_id":"NCT03220620","title":"Influence of Perioperative Fluid Therapy on Hemoglobin and Methemoglobin Levels","phase":"","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"University of Rostock","has_results":false},{"nct_id":"NCT03655678","title":"A Safety and Efficacy Study Evaluating CTX001 in Participants With Transfusion-Dependent β-Thalassemia","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":59,"lead_sponsor_name":"Vertex Pharmaceuticals Incorporated","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}